These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment. Träger M; Schweizer L; Pérez E; Schmid S; Hain EG; Dittmayer C; Onken J; Fukuoka K; Ichimura K; Schüller U; Dührsen L; Müther M; Paulus W; Thomas C; Gutt-Will M; Schucht P; Maragkou T; Schittenhelm J; Eckert F; Niyazi M; Fleischmann DF; Dorostkar MM; Feyer P; May SA; Moskopp D; Badakhshi H; Radke C; Walter J; Ehret F; Capper D; Kaul D Neuro Oncol; 2023 Jul; 25(7):1286-1298. PubMed ID: 36734226 [TBL] [Abstract][Full Text] [Related]
8. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077 [TBL] [Abstract][Full Text] [Related]
9. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252 [TBL] [Abstract][Full Text] [Related]
10. Implications of DNA Methylation Classification in Diagnosing Ependymoma. Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644 [TBL] [Abstract][Full Text] [Related]
11. Morphology-based molecular classification of spinal cord ependymomas using deep neural networks. Schumann Y; Dottermusch M; Schweizer L; Krech M; Lempertz T; Schüller U; Neumann P; Neumann JE Brain Pathol; 2024 Sep; 34(5):e13239. PubMed ID: 38205683 [TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma. Thomas C; Thierfelder F; Träger M; Soschinski P; Müther M; Edelmann D; Förster A; Geiler C; Kim HY; Filipski K; Harter PN; Schittenhelm J; Eckert F; Ntoulias G; May SA; Stummer W; Onken J; Vajkoczy P; Schüller U; Heppner FL; Capper D; Koch A; Kaul D; Paulus W; Hasselblatt M; Schweizer L Acta Neuropathol; 2021 Jun; 141(6):959-970. PubMed ID: 33755803 [TBL] [Abstract][Full Text] [Related]
13. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling. Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744 [TBL] [Abstract][Full Text] [Related]
14. Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. Heim S; Sill M; Jones DT; Vasiljevic A; Jouvet A; Fèvre-Montange M; Wesseling P; Beschorner R; Mittelbronn M; Kohlhof P; Hovestadt V; Johann P; Kool M; Pajtler KW; Korshunov A; Ruland V; Sperveslage J; Thomas C; Witt H; von Deimling A; Paulus W; Pfister SM; Capper D; Hasselblatt M Brain Pathol; 2016 Mar; 26(2):199-205. PubMed ID: 26113311 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity within the PF-EPN-B ependymoma subgroup. Cavalli FMG; Hübner JM; Sharma T; Luu B; Sill M; Zapotocky M; Mack SC; Witt H; Lin T; Shih DJH; Ho B; Santi M; Emery L; Hukin J; Dunham C; McLendon RE; Lipp ES; Gururangan S; Grossbach A; French P; Kros JM; van Veelen MC; Rao AAN; Giannini C; Leary S; Jung S; Faria CC; Mora J; Schüller U; Alonso MM; Chan JA; Klekner A; Chambless LB; Hwang EI; Massimino M; Eberhart CG; Karajannis MA; Lu B; Liau LM; Zollo M; Ferrucci V; Carlotti C; Tirapelli DPC; Tabori U; Bouffet E; Ryzhova M; Ellison DW; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Pfister SM; Taylor MD; Aldape K; Pajtler KW; Kool M; Ramaswamy V Acta Neuropathol; 2018 Aug; 136(2):227-237. PubMed ID: 30019219 [TBL] [Abstract][Full Text] [Related]
20. Utility of copy number variants in the classification of intracranial ependymoma. Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]